Cargando…
Biomarkers in community-acquired pneumonia: A state-of-the-art review
Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biologic...
Autores principales: | Seligman, Renato, Ramos-Lima, Luis Francisco, do Amaral Oliveira, Vivian, Sanvicente, Carina, Pacheco, Elyara F., Rosa, Karoline Dalla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488993/ https://www.ncbi.nlm.nih.gov/pubmed/23184211 http://dx.doi.org/10.6061/clinics/2012(11)17 |
Ejemplares similares
-
Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia,
por: Seligman, Renato, et al.
Publicado: (2013) -
Developing the Pneumonia-Optimized Ratio for Community-acquired pneumonia: An easy, inexpensive and accurate prognostic biomarker
por: Cury, Vinícius Ferraz, et al.
Publicado: (2021) -
Biomarkers in Pediatric Community-Acquired Pneumonia
por: Principi, Nicola, et al.
Publicado: (2017) -
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia
por: Seligman, Renato, et al.
Publicado: (2008) -
Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)